GeneDx Corp. (WGS)
NASDAQ: WGS
· Real-Time Price · USD
120.27
1.85 (1.56%)
At close: Oct 17, 2025, 3:19 PM
GeneDx Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 305.45M | 202.57M | 234.69M | 212.19M |
Cost of Revenue | 111.05M | 141.94M | 261.44M | 228.8M |
Gross Profit | 194.4M | 60.62M | -26.75M | -16.6M |
Operating Income | -23.21M | -163.66M | -667.65M | -446.15M |
Interest Income | n/a | 1.11M | 2.54M | 79K |
Pretax Income | -52.63M | -176.69M | -598.03M | -245.39M |
Net Income | -52.29M | -175.77M | -548.98M | -245.39M |
Selling & General & Admin | 168.48M | 194.71M | 338.24M | 318.73M |
Research & Development | 45.72M | 58.27M | 86.2M | 105.16M |
Other Expenses | 3.41M | -28.69M | 216.46M | 5.66M |
Operating Expenses | 217.61M | 224.28M | 640.9M | 429.55M |
Interest Expense | 3.03M | n/a | 3.21M | 2.83M |
Selling & Marketing Expenses | 67.37M | 60.96M | 122.08M | 112.74M |
Cost & Expenses | 328.66M | 366.23M | 902.35M | 658.34M |
Income Tax Expense | -343K | -926K | -49.05M | n/a |
Shares Outstanding (Basic) | 26.89M | 24.31M | 10.24M | 3.28M |
Shares Outstanding (Diluted) | 26.89M | 24.31M | 10.24M | 3.28M |
EPS (Basic) | -1.94 | -7.23 | -53.63 | -74.93 |
EPS (Diluted) | -1.94 | -7.23 | -53.63 | -74.93 |
EBITDA | -27.64M | -136.46M | -398.2M | -219.19M |
EBIT | -49.6M | -170.19M | -457.51M | -242.56M |
Depreciation & Amortization | 21.95M | 33.73M | 59.31M | 23.36M |
Source: Financial Modeling Prep. Financial Sources.